Lippincott ® NursingCenter ® Wolters Kluwer Logo

Nivolumab + Ipilimumab for High-Risk Uveal Melanoma Patients

Source:

Oncology Times

July 2024, Volume :46 Number 7 , page 22 - 22 [Free]

Go to article

Authors

  1. Nalley , Catlin

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

CE Resources

Nursing Resources

About NursingCenter

 

© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.09.00